Data protection Impressum

R&D

Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGS Beteiligungen (EGSB) to fuel its next phase of growth and global expansion.

Spineart raises CHF 25 million to accelerate global expansion and innovation

6 October 2025

Nestlé has reinforced its global expertise in child nutrition with the inauguration of a state-of-the-art quality laboratory at its Konolfingen site in the canton of Bern. The CHF 17.5 million investment, which created six new jobs, is the latest in a decade-long modernization effort that has seen nearly CHF 150 million invested at the site.

Nestlé strengthens child nutrition hub in Konolfingen with new quality laboratory

30 September 2025

Switzerland Innovation has launched an interactive map to simplify access to its network of innovation parks, offering international companies and partners a clearer entry point into Switzerland’s diverse R&D landscape.

Switzerland Innovation unveils new map to strengthen international visibility of its ecosystem

29 September 2025

Switzerland remains the world’s most innovative economy for the 15th year in a row, excelling in knowledge creation, diffusion and impact.

Switzerland tops global innovation ranking for the 15th consecutive year

23 September 2025

A new automated platform developed by cellvie and CSEM streamlines mitochondria isolation, advancing therapeutic transplantation for ischemia-reperfusion injury.

CSEM and cellvie automate mitochondria isolation for clinical use

9 September 2025

Pilatus Biosciences launches first-in-human trial in collaboration with Roche

20 August 2025

From Saint-Blaise, in the canton of Neuchâtel, SeaNest is designing modular floating platforms, partly made from recycled plastics, to create sustainable habitats on water.

Neuchâtel’s SeaNest develops floating platform technology to meet rising sea level challenges

11 August 2025

Two start-ups from Western Switzerland’s Health Valley, AzureCell Therapies and Myriad Optics, have each been awarded CHF 150,000 through the Gebert Rüf Stiftung’s Innobooster programme, which supports high-potential projects emerging from Swiss universities.

AzureCell Therapies and Myriad Optics awarded by Gebert Rüf Stiftung’s Innobooster programme

11 August 2025

Biopôle has evolved its Start Up Fund into a 24 month scheme combining non dilutive capital, investor training and growth support.

Biopôle launches enhanced Investment Programme to boost life sciences start‑ups

6 August 2025

Neuchâtel, renowned globally for its watchmaking heritage, has evolved into a dynamic hub of cutting-edge innovation. Today, the canton leverages its tradition of precision craftsmanship to excel in fields as diverse as blockchain, quantum technology, renewable energy, life sciences, and advanced manufacturing. The canton of Neuchâtel’s transformation highlights its unique ability to merge historical excellence with visionary innovation, positioning itself as a leading force within Switzerland’s economic landscape.

Neuchâtel, a legacy of precision driving tomorrow’s innovation

1 2 3 4 5 6 … 16